Stock 6847 PURIBLOOD MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Puriblood Medical Co., Ltd.

Equities

6847

TW0006847007

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 23/06/2024 BST 		5-day change 1st Jan Change
109.5 TWD -0.90% Intraday chart for Puriblood Medical Co., Ltd. -2.23% -2.67%
03-29 Puriblood Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Puriblood Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 2,305 1,928 1,601
Enterprise Value (EV) 1 2,204 1,885 1,535
P/E ratio -49.7 x 117 x -31 x
Yield - - -
Capitalization / Revenue 42.2 x 14 x 12.8 x
EV / Revenue 40.4 x 13.7 x 12.3 x
EV / EBITDA -72 x 140 x -35 x
EV / FCF -59.8 x -39 x 41.3 x
FCF Yield -1.67% -2.56% 2.42%
Price to Book 10.6 x 8.27 x 8.84 x
Nbr of stocks (in thousands) 14,230 14,230 14,230
Reference price 2 162.0 135.5 112.5
Announcement Date 27/04/22 27/04/23 29/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 38.65 54.59 137.4 125.3
EBITDA 1 0.068 -30.59 13.46 -43.87
EBIT 1 -3.296 -35.4 7.238 -50.4
Operating Margin -8.53% -64.84% 5.27% -40.24%
Earnings before Tax (EBT) 1 -2.779 -38.02 16.94 -54.43
Net income 1 -2.779 -38.02 16.53 -51.6
Net margin -7.19% -69.66% 12.03% -41.19%
EPS 2 -0.3231 -3.263 1.160 -3.630
Free Cash Flow 1 -17.15 -36.87 -48.33 37.16
FCF margin -44.39% -67.55% -35.16% 29.67%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 27/04/22 27/04/22 27/04/23 29/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 66 102 42.9 65.8
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -17.2 -36.9 -48.3 37.2
ROE (net income / shareholders' equity) -3.25% -21.1% 7.36% -24.9%
ROA (Net income/ Total Assets) -1.46% -9.58% 1.54% -10.8%
Assets 1 189.9 396.8 1,071 479.9
Book Value Per Share 2 14.00 15.20 16.40 12.70
Cash Flow per Share 2 11.60 9.270 6.990 8.260
Capex 1 9.85 3.15 2.21 6.25
Capex / Sales 25.49% 5.76% 1.61% 4.99%
Announcement Date 27/04/22 27/04/22 27/04/23 29/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
PURIBLOOD MEDICAL CO., LTD. Stock Puriblood Medical Co., Ltd.
-2.67% 48.12M
SHOCKWAVE MEDICAL Stock Shockwave Medical
+75.69% 12.57B
MASIMO CORPORATION Stock Masimo Corporation
+9.83% 6.83B
PENUMBRA, INC. Stock Penumbra, Inc.
-30.67% 6.76B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+8.94% 5.2B
GETINGE AB Stock Getinge AB
-19.62% 4.69B
APT MEDICAL INC. Stock APT Medical Inc.
+15.21% 4.1B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-22.82% 3.81B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-29.17% 2.67B
NOVOCURE LIMITED Stock NovoCure Limited
+25.39% 2.01B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 6847 Stock
  4. Financials Puriblood Medical Co., Ltd.